Drugs produced in U.S.-owned and operated pharmaceutical manufacturing plants in Puerto Rico are more likely to have quality problems than those produced by the same firm in a matched plant on the mainland, a study released Tuesday by Ohio State University's Fisher College of Business.
Merck & Co.’s reported plans to cut back its workforce by about 13,000 by 2015 will not affect its local operations, Frank Gutiérrez, general manager of Merck Puerto Rico and the Caribbean, said Friday.
Pharmaceutical companies doing business in Puerto Rico will not show any significant growth this year, pressured by upcoming patent expirations and underperforming economic conditions, Irish research firm Research and Markets said in its most recent industry report.
When space shuttle Atlantis took off on its final mission Friday, it was carrying a crew of special tiny passengers that are part of an advanced research and development project that could benefit humans for decades to come.
Puerto Rico has one of the world’s most competitive manufacturing foundations, but one of the most underdeveloped research and development economies, which poses an inarguable need to establish mechanisms to foster the right conditions for it to flourish, a high-ranking manufacturing executive recently told News is my Business.
Cordis Corporation, a subsidiary of Johnson & Johnson, announced Wednesday the discontinuation of production of its Cypher Stent product by the end of 2011, representing the closing of its plant in San Germán. The decision will leave 450 people jobless.
Contract manufacturer Legacy Pharmaceuticals PR, LLC announced Monday investment plans to expand its Humacao complex, where it produces and packages a variety of over-the-counter and prescription drugs in tablet and liquid forms.
Ireland-based specialty pharmaceutical company Warner Chilcott on Monday announced plans to restructure its European operations and finalize the conversion of its Manatí plant into a warehouse, supposing the elimination of 87 jobs effective mid-May.
Stateside pharmaceutical industry analysts placed their bets this week on whether Johnson & Johnson officials will decide to temporarily shut down the McNeil production plant in Las Piedras to correct manufacturing problems that have led to a string of major recalls in the last year.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
NIMB ON SOCIAL MEDIA